Bruce Amiot

Membrane pore size impacts performance of a xenogeneic bioartificial liver.

Cytotoxic immune response to a xenogeneic bioartificial liver.

Rapid, large-scale formation of porcine hepatocyte spheroids in a novel spheroid reservoir bioartificial liver.

Rat hepatocyte spheroids formed by rocked technique maintain differentiated hepatocyte gene expression and function.

Gene expression and functional analyses of primary rat hepatocytes on nanofiber matrices.

Optimization of mass transfer for toxin removal and immunoprotection of hepatocytes in a bioartificial liver.

Engineering analysis and development of the spheroid reservoir bioartificial liver.

E-cadherin protects primary hepatocyte spheroids from cell death by a caspase-independent mechanism.

Cell therapies for liver diseases.

Hepatocyte-like cells differentiated from human induced pluripotent stem cells: relevance to cellular therapies.

Serum-free medium and mesenchymal stromal cells enhance functionality and stabilize integrity of rat hepatocyte spheroids.

Cold storage of rat hepatocyte spheroids.

Fumarylacetoacetate hydrolase deficient pigs are a novel large animal model of metabolic liver disease.

Noninvasive 3-dimensional imaging of liver regeneration in a mouse model of hereditary tyrosinemia type 1 using the sodium iodide symporter gene.

Pivotal preclinical trial of the spheroid reservoir bioartificial liver.

Reply to: "Pivotal preclinical trial of the spheroid reservoir bioartificial liver".

Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1.

Chronic Phenotype Characterization of a Large-Animal Model of Hereditary Tyrosinemia Type 1.

Association between kidney intracapsular pressure and ultrasound elastography.

Hepatocyte spheroids as an alternative to single cells for transplantation after ex vivo gene therapy in mice and pig models.

Randomized Trial of Spheroid Reservoir Bioartificial Liver in Porcine Model of Post-Hepatectomy Liver Failure.